These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. Rütter A; Luger TA J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of immunomodulatory action of intravenous immunoglobulin in autoimmune and systemic inflammatory diseases. Vassilev T; Kazatchkine MD Ther Apher; 1997 Feb; 1(1):38-41. PubMed ID: 10225779 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of immune regulation by IVIG. Ballow M Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):509-15. PubMed ID: 25337683 [TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases. Ruiz de Souza V; Kaveri SV; Kazatchkine MD Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005 [TBL] [Abstract][Full Text] [Related]
15. Immunoregulation of autoimmune disorders: the role of intravenous immunoglobulins. Luzi G; Ferrara R Int J Artif Organs; 1993 Dec; 16 Suppl 5():189-95. PubMed ID: 8013987 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders. Larroche C; Chanseaud Y; Garcia de la Pena-Lefebvre P; Mouthon L BioDrugs; 2002; 16(1):47-55. PubMed ID: 11909001 [TBL] [Abstract][Full Text] [Related]